Inventiva IVA
NASDAQ IVA
$4.78 -0.06 (-1.24%)
As of: Sep 4, 2026 · 3:59 PM EDT

Inventiva (IVA) Cash & Equivalents (2018 - 2025)

Inventiva (IVA) posted quarterly Cash & Equivalents of $115.6 million for Q4 2025, up 11.99% year-over-year from $103.2 million in Q4 2024, and down 16.34% quarter-over-quarter from $138.2 million in Q2 2025.

Analysis

Inventiva (IVA) Cash & Equivalents (2018 - 2025) Analysis & Trends

Inventiva's Cash & Equivalents history runs 8 years deep, the most recent figure standing at $115.6 million for Q4 2025.

  • In Q4 2025, Cash & Equivalents rose 11.99% year-over-year to $115.6 million; the TTM figure through Dec 2025 stood at $115.6 million (up 11.99% YoY), while the FY2025 annual figure was $115.6 million, up 11.99% from the prior year.
  • Cash & Equivalents for Q4 2025 stood at $115.6 million, down from $138.2 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $138.2 million in Q2 2025, with the low at $10.9 million in Q2 2024.
  • The 5-year median for Cash & Equivalents is $93.8 million (2021), against an average of $79.6 million.
  • The sharpest annual moves came in 2024 and 2025: Cash & Equivalents tumbled 67.88% in 2024, then jumped 1164.6% in 2025.
  • Inventiva's Cash & Equivalents stood at $99.0 million in 2021, then declined by 10.63% to $88.5 million in 2022, then plunged by 67.27% to $29.0 million in 2023, then soared by 256.42% to $103.2 million in 2024, then increased by 11.99% to $115.6 million in 2025.
  • Business Quant data shows IVA's Cash & Equivalents at $115.6 million in Q4 2025, $138.2 million in Q2 2025, and $103.2 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 6.14 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 2.46 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 3.58 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 1.72 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 815.44 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 5.10 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.71 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 811.99 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 544.80 Mn
10 Inventiva 893.85 Mn 893.85 Mn - 115.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 115.60 Mn
Jun 30, 2025 138.19 Mn
Dec 31, 2024 103.19 Mn
Jun 30, 2024 10.93 Mn
Dec 31, 2023 28.96 Mn
Jun 30, 2023 34.02 Mn
Dec 31, 2022 88.49 Mn
Jun 30, 2022 81.53 Mn
Dec 31, 2021 99.01 Mn
Jun 30, 2021 112.76 Mn
Mar 31, 2021 130.04 Mn
Dec 31, 2020 126.01 Mn
Jun 30, 2020 57.58 Mn
Dec 31, 2019 39.67 Mn
Dec 31, 2018 64.71 Mn